Your browser doesn't support javascript.
Assessment of humoral responses in COVID-19 using various quantitative antibody tests.
Wakui, Masatoshi; Uwamino, Yoshifumi; Kurafuji, Toshinobu; Noguchi, Masayo; Ohno, Akemi; Yokota, Hiromitsu; Kikuchi, Haruhito; Hasegawa, Naoki; Saya, Hideyuki; Murata, Mitsuru.
  • Wakui M; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Uwamino Y; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kurafuji T; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
  • Noguchi M; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
  • Ohno A; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
  • Yokota H; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
  • Kikuchi H; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
  • Hasegawa N; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Saya H; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
  • Murata M; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
Ann Clin Biochem ; 58(4): 368-376, 2021 07.
Article in English | MEDLINE | ID: covidwho-1175245
ABSTRACT

BACKGROUND:

Quantitative antibody tests are expected to be useful in diagnostics of COVID-19 and investigation of herd immunity against SARS-CoV-2. To make it proper to perform them, understanding of the immunological aspects is critically important. The present study aimed to assess humoral responses in COVID-19 using various quantitative antibody tests.

METHODS:

Four quantitative antibody tests that are different in targeted antigens, detectable immunoglobulin classes and avidity were used. Diagnosis was confirmed by RT-PCR for SARS-CoV-2 detection. Antibody titres of 117 samples collected from 24 COVID-19 patients and 23 non-COVID-19 patients were measured to evaluate correlations between different tests. For 24 COVID-19 patients, antibody titres measured at various time points after the onset or the RT-PCR diagnosis were subjected to assessment of humoral responses.

RESULTS:

Correlations between tests were observed to some degree, although there were discrepancies putatively due to differences in measurement principle. Seronegative COVID-19 was diagnosed for some patients, in whom antibody titres were less than the cut-off value in each test throughout the time courses. IgG seroconversion without prior IgM seroconversion most frequently occurred, while predominance of IgM responses over IgG responses was observed in some severe cases. Viral burdens estimated according to threshold cycle values at the RT-PCR seemed to impact antibody responses.

CONCLUSIONS:

The results provide insights into the nature of humoral responses to SARS-CoV-2 and diagnostic performance of antibody tests.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / Immunoglobulin M / Immunity, Humoral / COVID-19 Nucleic Acid Testing / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Experimental Studies Limits: Female / Humans / Male Language: English Journal: Ann Clin Biochem Year: 2021 Document Type: Article Affiliation country: 00045632211006740

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / Immunoglobulin M / Immunity, Humoral / COVID-19 Nucleic Acid Testing / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Diagnostic study / Experimental Studies Limits: Female / Humans / Male Language: English Journal: Ann Clin Biochem Year: 2021 Document Type: Article Affiliation country: 00045632211006740